Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Physiol Cell Physiol ; 306(10): C899-909, 2014 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-24598361

RESUMO

Proline-rich protein tyrosine kinase 2 (Pyk2) is a member of the focal adhesion kinase family. We used Pyk2 knockout (Pyk2-KO) mice to study the role of Pyk2 in cutaneous wound repair. We report that the rate of wound closure was delayed in Pyk2-KO compared with control mice. To examine whether impaired wound healing of Pyk2-KO mice was caused by a keratinocyte cell-autonomous defect, the capacities of primary keratinocytes from Pyk2-KO and wild-type (WT) littermates to heal scratch wounds in vitro were compared. The rate of scratch wound repair was decreased in Pyk2-KO keratinocytes compared with WT cells. Moreover, cultured human epidermal keratinocytes overexpressing the dominant-negative mutant of Pyk2 failed to heal scratch wounds. Conversely, stimulation of Pyk2-dependent signaling via WT Pyk2 overexpression induced accelerated scratch wound closure and was associated with increased expression of matrix metalloproteinase (MMP)-1, MMP-9, and MMP-10. The Pyk2-stimulated increase in the rate of scratch wound repair was abolished by coexpression of the dominant-negative mutant of PKCδ and by GM-6001, a broad-spectrum inhibitor of MMP activity. These results suggest that Pyk2 is essential for skin wound reepithelialization in vivo and in vitro and that it regulates epidermal keratinocyte migration via a pathway that requires PKCδ and MMP functions.


Assuntos
Quinase 2 de Adesão Focal/genética , Queratinócitos/metabolismo , Proteína Quinase C-delta/metabolismo , Reepitelização/genética , Pele/metabolismo , Animais , Movimento Celular/efeitos dos fármacos , Células Cultivadas , Dipeptídeos/farmacologia , Quinase 2 de Adesão Focal/deficiência , Regulação da Expressão Gênica , Genes Dominantes , Humanos , Queratinócitos/citologia , Queratinócitos/efeitos dos fármacos , Masculino , Metaloproteinase 1 da Matriz/genética , Metaloproteinase 1 da Matriz/metabolismo , Metaloproteinase 10 da Matriz/genética , Metaloproteinase 10 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/genética , Metaloproteinase 9 da Matriz/metabolismo , Inibidores de Metaloproteinases de Matriz/farmacologia , Camundongos , Camundongos Knockout , Proteína Quinase C-delta/genética , Transdução de Sinais , Pele/efeitos dos fármacos , Pele/lesões
2.
Science ; 306(5693): 108-11, 2004 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-15459390

RESUMO

We show that activated collagenase (MMP-1) moves processively on the collagen fibril. The mechanism of movement is a biased diffusion with the bias component dependent on the proteolysis of its substrate, not adenosine triphosphate (ATP) hydrolysis. Inactivation of the enzyme by a single amino acid residue substitution in the active center eliminates the bias without noticeable effect on rate of diffusion. Monte Carlo simulations using a model similar to a "burnt bridge" Brownian ratchet accurately describe our experimental results and previous observations on kinetics of collagen digestion. The biological implications of MMP-1 acting as a molecular ratchet tethered to the cell surface suggest new mechanisms for its role in tissue remodeling and cell-matrix interaction.


Assuntos
Colágeno/metabolismo , Metaloproteinase 1 da Matriz/metabolismo , Trifosfato de Adenosina/metabolismo , Substituição de Aminoácidos , Animais , Simulação por Computador , Difusão , Fluorescência , Humanos , Hidrólise , Matemática , Metaloproteinase 1 da Matriz/química , Metaloproteinase 1 da Matriz/genética , Microscopia de Fluorescência , Modelos Químicos , Proteínas Motores Moleculares/química , Proteínas Motores Moleculares/metabolismo , Método de Monte Carlo , Mutação Puntual , Transporte Proteico , Ratos , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo
3.
J Biol Chem ; 277(18): 16022-7, 2002 May 03.
Artigo em Inglês | MEDLINE | ID: mdl-11839746

RESUMO

Expression of gelatinase B (matrix metalloprotease 9) in human placenta is developmentally regulated, presumably to fulfill a proteolytic function. Here we demonstrate that gelatinolytic activity in situ, in tissue sections of term placenta, is co-localized with gelatinase B. Judging by molecular mass, however, all the enzyme extracted from this tissue was found in a proform. To address this apparent incongruity, we examined the activity of gelatinase B bound to either gelatin- or type IV collagen-coated surfaces. Surprisingly, we found that upon binding, the purified proenzyme acquired activity against both the fluorogenic peptide (7-methoxycoumarin-4-yl)-acetic acid (MCA)-Pro-Leu-Gly-Leu-3-(2,4-dinitrophenyl)-l-2,3-diaminopropionyl-Ala-Arg-NH(2) and gelatin substrates, whereas its propeptide remained intact. These results suggest that although activation of all known matrix metalloproteases in vitro is accomplished by proteolytic processing of the propeptide, other mechanisms, such as binding to a ligand or to a substrate, may lead to a disengagement of the propeptide from the active center of the enzyme, causing its activation.


Assuntos
Precursores Enzimáticos/metabolismo , Metaloproteinase 2 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Sítios de Ligação , Dimerização , Feminino , Humanos , Cinética , Metaloproteinase 3 da Matriz/farmacologia , Inibidores de Metaloproteinases de Matriz , Placenta/enzimologia , Gravidez , Especificidade por Substrato , Inibidor Tecidual de Metaloproteinase-1/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...